| Website | dpbioventures.com |
| Phone | 484-320-4900 |
| Employees | |
| Description | Life Sciences Venture Firm |
Devon Park Bioventures is a venture capital fund targeting investments in therapeutics companies and, in certain cases, medical device, diagnostic and drug discovery technology companies.
| Company | Date | Round | Size | Participants |
| ZS Pharma | 10/12 | Series C | $46M | 5 |
| Vascular Magnetics | 2/12 | Series A | $7M | 1 |
| Cara Therapeutics | 7/10 | Series D | $15M | 8 |
| Inotek Pharmaceuticals | 6/10 | Series D | $18M | 5 |
| Cempra | 6/09 | Series C | $46M | 6 |
| Proteon Therapeutics | 5/09 | Series B | $50M | 8 |